Literature DB >> 27811009

Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.

Erik Hedrick1, Xi Li1, Stephen Safe2.   

Abstract

It was recently demonstrated the penfluridol inhibited breast tumor growth and metastasis and this was associated with downregulation of α6- and β4-integrins. In this study, we observed the penfluridol induced reactive oxygen species (ROS) and this was the primary mechanism of action. Penfluridol-mediated growth inhibition, induction of apoptosis, and inhibition of breast cancer cell migration was attenuated after cotreatment with glutathione. Penfluridol also downregulated Sp transcription factors Sp1, Sp3, and Sp4 through epigenetic downregulation of cMyc and cMyc-regulated miRNAs (miR27a and miR20a/miR17) and induction of the miR-regulated Sp transcriptional repressors ZBTB10 and ZBTB4. α6- and β4-integrins as well as α5- and β1-integrins are Sp-regulated genes that are also coregulated by the orphan nuclear receptor NR4A1 and these integrins can be targeted by agents such as penfluridol that suppress Sp1, Sp3, and Sp4 and also by NR4A1 antagonists. Mol Cancer Ther; 16(1); 205-16. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27811009      PMCID: PMC5222719          DOI: 10.1158/1535-7163.MCT-16-0451

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  44 in total

1.  Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.

Authors:  Satya S Pathi; Ping Lei; Sandeep Sreevalsan; Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Nutr Cancer       Date:  2011-09-15       Impact factor: 2.900

2.  Identification of the human alpha6 integrin gene promoter.

Authors:  C S Lin; Y Chen; T Huynh; R Kramer
Journal:  DNA Cell Biol       Date:  1997-08       Impact factor: 3.311

3.  Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Maen Abdelrahim; Md Riyaz Basha; Ismael Samudio; Marina Konopleva; Michael Andreeff; Stephen Safe
Journal:  Mol Pharmacol       Date:  2010-05-20       Impact factor: 4.436

Review 4.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

5.  Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.

Authors:  Syng-Ook Lee; Maen Abdelrahim; Kyungsil Yoon; Sudhakar Chintharlapalli; Sabitha Papineni; Kyounghyun Kim; Huamin Wang; Stephen Safe
Journal:  Cancer Res       Date:  2010-07-21       Impact factor: 12.701

6.  β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.

Authors:  Hoa H Truong; Jiangling Xiong; Veerander P S Ghotra; Ella Nirmala; Lizette Haazen; Sylvia E Le Dévédec; Hayri E Balcioğlu; Shuning He; B Ewa Snaar-Jagalska; Erno Vreugdenhil; John H N Meerman; Bob van de Water; Erik H J Danen
Journal:  Sci Signal       Date:  2014-02-11       Impact factor: 8.192

7.  Targeting oxidative stress in embryonal rhabdomyosarcoma.

Authors:  Xiang Chen; Elizabeth Stewart; Anang A Shelat; Chunxu Qu; Armita Bahrami; Mark Hatley; Gang Wu; Cori Bradley; Justina McEvoy; Alberto Pappo; Sheri Spunt; Marcus B Valentine; Virginia Valentine; Fred Krafcik; Walter H Lang; Monika Wierdl; Lyudmila Tsurkan; Viktor Tolleman; Sara M Federico; Chris Morton; Charles Lu; Li Ding; John Easton; Michael Rusch; Panduka Nagahawatte; Jianmin Wang; Matthew Parker; Lei Wei; Erin Hedlund; David Finkelstein; Michael Edmonson; Sheila Shurtleff; Kristy Boggs; Heather Mulder; Donald Yergeau; Steve Skapek; Douglas S Hawkins; Nilsa Ramirez; Philip M Potter; John A Sandoval; Andrew M Davidoff; Elaine R Mardis; Richard K Wilson; Jinghui Zhang; James R Downing; Michael A Dyer
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

8.  Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.

Authors:  Erik Hedrick; Yating Cheng; Un-Ho Jin; Kyounghyun Kim; Stephen Safe
Journal:  Oncotarget       Date:  2016-04-19

9.  P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells.

Authors:  André Filipe Vieira; Ana Sofia Ribeiro; Maria Rita Dionísio; Bárbara Sousa; Ana Rita Nobre; André Albergaria; Angélica Santiago-Gómez; Nuno Mendes; Renê Gerhard; Fernando Schmitt; Robert B Clarke; Joana Paredes
Journal:  Oncotarget       Date:  2014-02-15

10.  Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis.

Authors:  Alok Ranjan; Sanjay K Srivastava
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more
  26 in total

1.  Bortezomib Targets Sp Transcription Factors in Cancer Cells.

Authors:  Keshav Karki; Sneha Harishchandra; Stephen Safe
Journal:  Mol Pharmacol       Date:  2018-08-16       Impact factor: 4.436

2.  Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.

Authors:  Erik Hedrick; Xi Li; Yating Cheng; Alexandra Lacey; Kumaravel Mohankumar; Mahsa Zarei; Stephen Safe
Journal:  Breast Cancer Res Treat       Date:  2019-05-22       Impact factor: 4.872

3.  Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells.

Authors:  Un-Ho Jin; Yating Cheng; Beiyan Zhou; Stephen Safe
Journal:  Mol Pharmacol       Date:  2017-03-08       Impact factor: 4.436

4.  TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Stephen Safe
Journal:  Mol Cancer Res       Date:  2018-08-02       Impact factor: 5.852

5.  LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer.

Authors:  Dan Zang; Chuang Zhang; Ce Li; Yibo Fan; Zhi Li; Kezuo Hou; Xiaofang Che; Yunpeng Liu; Xiujuan Qu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

6.  Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.

Authors:  Prasad Dandawate; Gaurav Kaushik; Chandrayee Ghosh; David Standing; Afreen Asif Ali Sayed; Sonali Choudhury; Dharmalingam Subramaniam; Ann Manzardo; Tuhina Banerjee; Santimukul Santra; Prabhu Ramamoorthy; Merlin Butler; Subhash B Padhye; Joaquina Baranda; Anup Kasi; Weijing Sun; Ossama Tawfik; Domenico Coppola; Mokenge Malafa; Shahid Umar; Michael J Soares; Subhrajit Saha; Scott J Weir; Animesh Dhar; Roy A Jensen; Sufi Mary Thomas; Shrikant Anant
Journal:  Gastroenterology       Date:  2019-11-29       Impact factor: 22.682

7.  Bis-Indole-Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells.

Authors:  Kumaravel Mohankumar; Jehoon Lee; Chia Shan Wu; Yuxiang Sun; Stephen Safe
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

8.  Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.

Authors:  Md Ashraf-Uz-Zaman; Md Sanaullah Sajib; Luca Cucullo; Constantinos M Mikelis; Nadezhda A German
Journal:  Bioorg Med Chem Lett       Date:  2018-10-24       Impact factor: 2.823

Review 9.  Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.

Authors:  Vikram Shaw; Suyash Srivastava; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2019-10-13       Impact factor: 15.707

10.  Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.

Authors:  Wen-Yueh Hung; Wei-Jiunn Lee; Guo-Zhou Cheng; Ching-Han Tsai; Yi-Chieh Yang; Tsung-Ching Lai; Ji-Qing Chen; Chi-Li Chung; Jer-Hwa Chang; Ming-Hsien Chien
Journal:  Cell Oncol (Dordr)       Date:  2021-07-28       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.